thymidine monophosphate has been researched along with Leukemia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
D'Cruz, OJ; Tai, HL; Uckun, FM | 1 |
Benyumov, AO; Downs, S; Dumezb, D; Grigoriants, OO; Tibbles, HE; Uckun, FM; Vassilev, AO; Venkatachalam, TK | 1 |
Aherne, GW; Barnes, MJ; Calvete, JA; Estlin, EJ; Hardcastle, A; Lunec, J; McGuire, JJ; Newell, DR; Pearson, AD; Taylor, GA | 1 |
Cranford, SK; Fernandes, DJ | 2 |
5 other study(ies) available for thymidine monophosphate and Leukemia
Article | Year |
---|---|
Antileukemic activity and cellular metabolism of the aryl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07).
Topics: Animals; Antimetabolites, Antineoplastic; Biotransformation; Carboxylic Ester Hydrolases; Cell Division; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Dideoxynucleotides; Drug Resistance, Multiple; Embryo, Nonmammalian; Glutathione; Humans; Leukemia; Nucleosides; Paraoxon; Rhodamine 123; Subcellular Fractions; Tetrazolium Salts; Thiazoles; Thymidine Monophosphate; Tumor Stem Cell Assay; Zebrafish; Zidovudine | 2005 |
Anti-proliferative and anti-leukemic activity of DDE46 (compound WHI-07), a novel bromomethoxylated arylphosphate derivative of zidovudine, and related compounds. Studies using human acute lymphoblastic leukemia cells and the zebrafish model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase Inhibitors; Cell Proliferation; Dideoxynucleotides; Drug Screening Assays, Antitumor; Humans; Jurkat Cells; Leukemia; Magnetic Resonance Spectroscopy; Nephelometry and Turbidimetry; Prodrugs; Tetrazolium Salts; Thiazoles; Thymidine Monophosphate; Tubulin; Zebrafish; Zidovudine | 2005 |
Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
Topics: Biological Transport; Cell Division; Drug Screening Assays, Antitumor; Folic Acid Antagonists; Growth Inhibitors; Humans; Inhibitory Concentration 50; Leukemia; Methotrexate; Peptide Synthases; Purines; Quinazolines; RNA, Messenger; Thiophenes; Thymidine Monophosphate; Thymidylate Synthase; Tumor Cells, Cultured | 1999 |
Dissociation of thymidylate biosynthesis from DNA biosynthesis by 5-fluoro-2'-deoxyuridine and 5,8-dideazaisofolic acid.
Topics: Deoxyguanine Nucleotides; DNA; DNA Polymerase II; Dose-Response Relationship, Drug; Floxuridine; Folic Acid Antagonists; Humans; Leukemia; Pyrimethamine; Quinazolines; Thymidine Monophosphate; Thymidylate Synthase; Thymine Nucleotides | 1986 |
Resistance of CCRF-CEM cloned sublines to 5-fluorodeoxyuridine associated with enhanced phosphatase activities.
Topics: Acid Phosphatase; Alkaline Phosphatase; Biological Transport; Clone Cells; Drug Resistance; Floxuridine; Fluorouracil; Humans; Leukemia; Thymidine Kinase; Thymidine Monophosphate | 1985 |